Clinical trial
Risperidone and Olanzapine for the Schizophrenic Patients With…
NCT00331825 · Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan, Other · Completed
Key facts
| NCT number | NCT00331825 |
|---|---|
| Title | Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism |
| Official title | A Randomized Controlled Trial Study of Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism |
| Lead sponsor | Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan, Other |
| Collaborators | Department of Health |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Extrapyramidal Syndrome |
| Intervention type | Drug |
| Interventions | Risperidone and Olanzapine |
| Enrollment | 70 |
| Start date | Jul 1, 2000 |
| Completion | Jul 1, 2003 |
| First posted | May 31, 2006 |
| Last update posted | May 31, 2006 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: